BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10491294)

  • 1. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
    Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
    Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells.
    Wickström SA; Alitalo K; Keski-Oja J
    Cancer Res; 2002 Oct; 62(19):5580-9. PubMed ID: 12359771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, expression, and in vitro activity of human endostatin.
    Dhanabal M; Volk R; Ramchandran R; Simons M; Sukhatme VP
    Biochem Biophys Res Commun; 1999 May; 258(2):345-52. PubMed ID: 10329390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
    Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
    Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin.
    Ramchandran R; Dhanabal M; Volk R; Waterman MJ; Segal M; Lu H; Knebelmann B; Sukhatme VP
    Biochem Biophys Res Commun; 1999 Feb; 255(3):735-9. PubMed ID: 10049780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of recombinant murine endostatin in E. coli.
    You WK; So SH; Lee H; Park SY; Yoon MR; Chang SI; Kim HK; Joe YA; Hong YK; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):197-202. PubMed ID: 10630374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing.
    Berger AC; Feldman AL; Gnant MF; Kruger EA; Sim BK; Hewitt S; Figg WD; Alexander HR; Libutti SK
    J Surg Res; 2000 Jun; 91(1):26-31. PubMed ID: 10816345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
    Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
    FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis.
    Xu R; Yao ZY; Xin L; Zhang Q; Li TP; Gan RB
    Biochem Biophys Res Commun; 2001 Nov; 289(1):264-8. PubMed ID: 11708810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.
    Bootle-Wilbraham CA; Tazzyman S; Marshall JM; Lewis CE
    Cancer Res; 2000 Sep; 60(17):4719-24. PubMed ID: 10987275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.